Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Losses Down, Revenues Up for Q1 of FY2004

NEW YORK, April 27 (GenomeWeb News) - Paradigm Genetics today reported an improved net loss and increased revenues for the first quarter of fiscal year 2004.

 

The company said it had a net loss of $3.7 million, as compared to $4.1 million for the same quarter last year. Total revenues increased to $4.9 million from $4.1 million during the same quarter last year.

 

As of March 31, Paradigm had $15.2 million in unrestricted cash, cash equivalents, and short-term investments.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.